Article Details

AstraZeneca, GSK, Teva All On FTC's Notice Due To "Improperly Listed" Patents

Retrieved on: 2023-11-08 17:30:17

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, GSK, Teva All On FTC's Notice Due To "Improperly Listed" Patents. View article details on hiswai:

Excerpt

The U.S. Federal Trade Commission (FTC) issued letters to various medical device companies and drugmakers, including AbbVie, AstraZeneca, ...

Article found on: thedeepdive.ca

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up